Biological Information
Background Information:
Myotonic dystrophy (DM1) is the most common form of muscular dystrophy in adults, caused by amplification of an unstable (CTG)n repeat in the 3' untranslated region (3'-UTR) of the DM1 protein kinase (DMPK) gene. Myotonic dystrophy protein kinase (DMPK) is a serine threonine kinase encoded by the DM-1 locus.
Family:
Kinase
Sub Family:
AGC
Class:
Protein Ser/Thr
Protein Name:
DMPK
Uniprot Number:
Q09013
Protein Aliases:
dystrophia myotonica 1|DM protein kinase|myotonin protein kinase A|myotonic dystrophy associated protein kinase|thymopoietin homolog
Gene Name:
DMPK
Gene ID:
1760
Gene Aliases:
DMK|DM1PK|MDPK|MT-PK
Accession Number:
NM_004409
Organism:
Human
Construct Details:
Fragment (1-549), Recombinant
Assay Information
Assay Type:
Biochemical
Assay Sub Type:
Enzymatic
Functional Mode:
Antagonist
Detection Method:
Radiometry
Measured Response:
Scintillation
Testing Information
Procedure Summary:
Human recombinant protein kinase DMPK expressed in insect Sf21 cells is used. Test compound and/or vehicle is preincubated with 37 mU/ml enzyme‡ in modified MOPS buffer pH 7.2 for 15 minutes at 37°C. The reaction is initiated by addition of 25 µM Axl-tide, 10 µM ATP and 0.25 µCi [γ32P]ATP for another 30 minute incubation period and terminated by further addition of 3% H3PO4. An aliquot is removed and counted to determine the amount of [32P]Axl-tide formed. Compounds are screened at 10 µM.
Substrate:
25 µM Axltide
ATP Concentration:
10 uM
Incubation:
30 min at 37°C
Control Inhibitor:
Staurosporine
Criteria For Significance:
≥ 50% of max stimulation or inhibition
Test Concentration / Dose:
Suggested concentration for initial testing is 10 uM
Test Sample Requirements:
Minimum for 1) Screen: 25 μl of 10 mM stock -OR- 1 mg (pre-weighed). 2) Dose Response: 60 μl of 10 mM stock -OR- 1 mg (pre-weighed).
Minimum Order Quantity:
10
Turnaround Time
Standard:
15 Business Days
Reference Compound Data
Clinical Relevance
Therapeutic Area:
Oncology/Immuno-Oncology
Adverse / Beneficial Action:
Permanent overexpression of DMPK may cause myotonic myopathy, hypertrophic cardiomyopathy with dysrhythmia and hypotension. DMPK inhibition, however, may cause typical myotonic dystrophy symptoms and heart conduction defects.
Additional Information
Brand:
LeadHunter
Testing Location:
Taiwan - Taipei
RELATED SOLUTIONS